Cloning, expression, purification and bioassay of human vasostatin

Progress in Biochemistry and Biophysics

Volumn 30, Issue 3, 2003, Pages 447-452

  Li, Yong Hong ^a   Wang, Jun Zhi ^a   Rao, Chun Ming ^a   Zhang, Yi ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Angiogenesis inhibitor; Bioassay; Gene clone; Gene expression; Vasostatin

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENTARY DNA; GENE PRODUCT; PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASOSTATIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; BACTERIAL CELL; BIOASSAY; CELL INCLUSION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; DIALYSIS; DNA LIBRARY; DNA SEQUENCE; DNA VECTOR; ENDOTHELIUM CELL; ESCHERICHIA COLI; EXTRACTION; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSFORMATION; HUMAN; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; ISOELECTRIC POINT; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PURIFICATION; PROTEIN RENATURATION; PROTEIN STRUCTURE; RECOMBINANT PLASMID; SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0041828600     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Good D J, Polverini P J, Rastinejad F, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombspondin. Proc Natl Acad Sci USA, 1990, 87 (17): 6624-6628
2. O'Reilly M S, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by lewis lung carcinoma. Cell, 1994, 79 (2): 315-328
3. O'Reilly M S, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogensis and tumor growth. Cell, 1997, 88 (2): 277-289
4. Kamphaus G D, Colorado P C, Panka D J, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem, 2000, 275 (2): 1209-1215
5. Pike S E, Yao L, Jones K D, et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med, 1998, 188 (12): 2349-2356
6. Yao L, Pike S E, Setsuda J, et al. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. Blood, 2000, 96 (5): 1900-1905
7. Pike S E, Yao L, Setsuda J, et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood, 1999, 94 (7): 2461-2468
8. Sambrook J, Fritsh E F, Maniatis J, et al. Transtaled by Jin D Y, Li M F, et al. Molecular Cloning: A Laboratory Manual. 2nd. Beijing: Sciences Press, 1992. 16-342
9. Zhang Y, Wang J Z, Wu Y J. Chin J Biotech, 2000, 16 (5): 557-560
10. Takano S, Gately S, Neville M E, et al. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res, 1994, 54 (10): 2654-2660
11. Li Y H, Wang J Z, Han C M, et al. Acta Pharmaceutica Sinica, 2002, 37 (10): 807-811
12. Fu S F, Lu Y L, Zhang C S, et al. Bulletin of the Academy of Military Medical Sciences, 1993, 17: 294
13. Sheng Q H, Zhou A R, Gao W, et al. Chin J Interventional Cardiology, 1999, 7 (2): 90-92